“Media experiences describe it like a loophole,” says Alliance for Pharmacy Compounding CEO Scott Brunner. “It’s not a loophole. It’s really intentional coverage.” Brunner has expressed irritation about how some coverage of your increase of compounding GLP-1s conflates unlicensed pharmacies peddling copyright medicine or investigation peptides with credentialed operations https://christk749dff1.wikicorrespondence.com/user